Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCDC99 |
| Upstream (Parents) |
|---|
| (<<) CEP55 → CCDC99 |
| (<<) CENPA → CCDC99 |
| (<<) CCNB1 → CCDC99 |
| (<<) PTTG1 → CCDC99 |
| (<<) NCAPG → CCDC99 |
| (<<) KIF14 → CCDC99 |
| Downstream (Children) |
|---|
| CCDC99 → GLI2 (>>) |
| CCDC99 → LOC646756///FOXRED2///TXN2///CACNG2///EIF3D (>>) |
| CCDC99 → ZNF613 (>>) |
| CCDC99 → MED27 (>>) |
| CCDC99 → FAM182A (>>) |
| CCDC99 → FUT8 (>>) |
| CCDC99 → HLA-DPA2 (>>) |
| CCDC99 → B3GNTL1 (>>) |
| CCDC99 → GAN (>>) |
| CCDC99 → SPATA6 (>>) |
| CCDC99 → MNS1 (>>) |
| CCDC99 → NDUFB7 (>>) |
| CCDC99 → ANP32E (>>) |
| CCDC99 → CDC7 (>>) |
